Real-World Efficacy and Hematologic Toxicity of Azacitidine and Venetoclax in a Cohort of Elderly Patients Unfit for Intensive Chemotherapy With Newly Diagnosed Acute Myeloid Leukemia

被引：0
|
作者：
Wysoglad, Hubert [1 ,2 ]
Krawczyk, Katarzyna [2 ,3 ]
Ochrem, Bogdan [2 ,3 ]
Madry, Krzysztof [1 ]
Drozd-Sokolowska, Joanna [1 ]
Sacha, Tomasz [2 ,3 ]
Basak, Grzegorz [1 ]
机构：
[1] Med Univ Warsaw, Dept Hematol Transplantol & Internal Med, Warsaw, Poland
[2] Univ Hosp Krakow, Dept Hematol, Krakow, Poland
[3] Jagiellonian Univ Med Coll, Dept Hematol, Krakow, Poland
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
acute myeloid leukemia; azacitidine; venetoclax; real-world evidence;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AML-384
引用
收藏
页码：S294 / S294
页数：1
相关论文
共 50 条
  • [21] A real-world study of infectious complications of venetoclax combined with decitabine or azacitidine in adult acute myeloid leukemia
    Zhu, Li-xia
    Chen, Rong-rong
    Wang, Lu-lu
    Sun, Jia-nai
    Zhou, De
    Li, Li
    Qian, Jie-jing
    Zhang, Yi
    Tong, Hong-yan
    Yu, Wen-juan
    Meng, Hai-tao
    Mai, Wen-yuan
    Xie, Wan-zhuo
    Jin, Jie
    Ye, Xiu-jin
    Zhu, Hong-hu
    SUPPORTIVE CARE IN CANCER, 2022, 30 (08) : 7031 - 7038
  • [22] AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia
    Todisco, Elisabetta
    Papayannidis, Cristina
    Fracchiolla, Nicola
    Petracci, Elisabetta
    Zingaretti, Chiara
    Vetro, Calogero
    Martelli, Maria Paola
    Zappasodi, Patrizia
    Di Renzo, Nicola
    Gallo, Susanna
    Audisio, Ernesta
    Griguolo, Davide
    Cerchione, Claudio
    Selleri, Carmine
    Mattei, Daniele
    Bernardi, Massimo
    Fumagalli, Monica
    Rizzuto, Giuliana
    Facchini, Luca
    Basilico, Claudia Maria
    Manfra, Ilenia
    Borlenghi, Erika
    Cairoli, Roberto
    Salutari, Prassede
    Gottardi, Michele
    Molteni, Alfredo
    Martini, Vincenza
    Lunghi, Monia
    Fianchi, Luana
    Cilloni, Daniela
    Lanza, Francesco
    Abruzzese, Elisabetta
    Cascavilla, Nicola
    Rivellini, Flavia
    Ferrara, Felicetto
    Maurillo, Luca
    Nanni, Jacopo
    Romano, Alessandra
    Cardinali, Valeria
    Gigli, Federica
    Roncoroni, Elisa
    Federico, Vincenzo
    Marconi, Giovanni
    Volpi, Roberta
    Sciume, Mariarita
    Tarella, Corrado
    Rossi, Giuseppe
    Martinelli, Giovanni
    CANCER, 2023, 129 (07) : 992 - 1004
  • [23] Phase 2 study of chidamide in combination with CAG and venetoclax-azacitidine in older patients with newly diagnosed acute myeloid leukemia
    Liu, Qingyang
    Yang, Jingjing
    Lv, Lei
    Zhang, Xiawei
    Li, Meng
    Xu, Lingmin
    Huang, Sai
    Jing, Yu
    Dou, Liping
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [24] Efficacy and Safety of Low-Dose Venetoclax Combined with Voriconazole Inpatients with Acute Myeloid Leukemia Unfit for Intensive Chemotherapy
    Meng, Danchen
    Ruan, Min
    Liu, Xinyao
    Wu, Wei
    Zhuang, Junling
    Ge, Jian
    Huang, Zhenqi
    Long, Zhangbiao
    BLOOD, 2023, 142
  • [25] Venetoclax in Combination with Azacitidine for the Treatment of Newly Diagnosed Acute Myeloid Leukemia: A Canadian Cost-Utility Analysis
    Guinan, Kimberly
    Mathurin, Karine
    Au, Yunghan
    Schuh, Andre C.
    Bui, Cat N.
    Chai, Xinglei
    Lachaine, Jean
    CURRENT ONCOLOGY, 2022, 29 (10) : 7524 - 7536
  • [26] Optimizing venetoclax dose in combination with low intensive therapies in elderly patients with newly diagnosed acute myeloid leukemia: An exposure-response analysis
    Agarwal, Suresh
    Gopalakrishnan, Sathej
    Mensing, Sven
    Potluri, Jalaja
    Hayslip, John
    Kirschbrown, Whitney
    Friedel, Anna
    Menon, Rajeev
    Salem, Ahmed Flamed
    HEMATOLOGICAL ONCOLOGY, 2019, 37 (04) : 464 - 473
  • [27] Ten-day decitabine as initial therapy for newly diagnosed patients with acute myeloid leukemia unfit for intensive chemotherapy
    Bhatnagar, Bhavana
    Duong, Vu H.
    Gourdin, Theodore S.
    Tidwell, Michael L.
    Chen, Ching
    Ning, Yi
    Emadi, Ashkan
    Sausville, Edward A.
    Baer, Maria R.
    LEUKEMIA & LYMPHOMA, 2014, 55 (07) : 1533 - 1537
  • [28] Real-World Experience of Measurable Residual Disease Response and Prognosis in Acute Myeloid Leukemia Treated with Venetoclax and Azacitidine
    Ong, Shin Yeu
    Yun, Melinda Tan Si
    Halim, Nurul Aidah Abdul
    Christopher, Dheepa
    Jen, Wei Ying
    Gallardo, Christian
    Yim, Angeline Tan Hwee
    Woon, Yeow Kheong
    Ng, Heng Joo
    Ooi, Melissa
    Wong, Gee Chuan
    CANCERS, 2022, 14 (15)
  • [29] Reduced duration and dosage of venetoclax is efficient in newly diagnosed patients with acute myeloid leukemia
    Cui, Jingying
    Chen, Xuexing
    Li, Chunfang
    Yan, Qiong
    Yuan, Guolin
    HEMATOLOGY, 2024, 29 (01)
  • [30] Venetoclax with Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Survival Data from Real-World Studies
    Ucciero, Andrealuna
    Pagnoni, Federico
    Scotti, Lorenza
    Pisterna, Alessia
    Barone-Adesi, Francesco
    Gaidano, Gianluca
    Patriarca, Andrea
    Lunghi, Monia
    CANCERS, 2023, 15 (18)
12345